Prescription of opioids for breathlessness in end-stage COPD: a national population-based study

References

• LozanoRNaghaviMForemanKGlobal and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010Lancet201238098592095212823245604
   PubMed Web of Science ®Google Scholar
• WalkeLMByersALTinettiMEDubinJAMcCorkleRFriedTRRange and severity of symptoms over time among older adults with chronic obstructive pulmonary disease and heart failureArch Intern Med2007167222503250818071174
   PubMed Web of Science ®Google Scholar
• JohnsonMJBowdenJAAbernethyAPCurrowDCTo what causes do people attribute their chronic breathlessness? A population surveyJ Palliat Med201215774475022687264
   PubMed Web of Science ®Google Scholar
• MüllerováHLuCLiHTabbererMPrevalence and burden of breathlessness in patients with chronic obstructive pulmonary disease managed in primary carePLoS One201491e8554024427316
   PubMed Web of Science ®Google Scholar
• MoensKHigginsonIJHardingREURO IMPACTAre There differences in the prevalence of palliative care-related problems in people living with advanced cancer and eight non-cancer conditions? A systematic reviewJ Pain Symptom Manage201448466067724801658
   PubMed Web of Science ®Google Scholar
• AhmadiZLundströmSJansonCEnd-of-life care in oxygen-dependent COPD and cancer: a national population-based studyEur Respir J20154641190119326250490
   PubMed Web of Science ®Google Scholar
• ElkingtonHWhitePAddington-HallJHiggsREdmondsPThe healthcare needs of chronic obstructive pulmonary disease patients in the last year of lifePalliat Med200519648549116218161
   PubMed Web of Science ®Google Scholar
• GulbasGGunenHInEKilicTLong-term follow-up of chronic obstructive pulmonary disease patients on long-term oxygen treatmentInt J Clin Pract201266215215722188416
   PubMed Web of Science ®Google Scholar
• LawSBoydSMacdonaldJRaesideDAndersonDPredictors of survival in patients with chronic obstructive pulmonary disease receiving long-term oxygen therapyBMJ Support Palliat Care201410.1136/bmjspcare-2012-000432
   Google Scholar
• AbernethyAPCurrowDCFrithPFazekasBSMcHughABuiCRandomised, double blind, placebo controlled crossover trial of sustained release morphine for the management of refractory dyspnoeaBMJ2003327741452352812958109
   PubMed Web of Science ®Google Scholar
• ParshallMBSchwartzsteinRMAdamsLAn official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspneaAm J Respir Crit Care Med2012185443545222336677
   PubMed Web of Science ®Google Scholar
• JenningsALDaviesANHigginsJPGibbsJSBroadleyKEA systematic review of the use of opioids in the management of dyspnoeaThorax2002571193994412403875
   PubMed Web of Science ®Google Scholar
• JanssenDJSpruitMAUszko-LencerNHScholsJMWoutersEFSymptoms, comorbidities, and health care in advanced chronic obstructive pulmonary disease or chronic heart failureJ Palliat Med201114673574321510771
   PubMed Web of Science ®Google Scholar
• AuDHUdrisEMFihnSDMcDonellMBCurtisJRDifferences in health care utilization at the end of life among patients with chronic obstructive pulmonary disease and patients with lung cancerArch Intern Med2006166332633116476873
   PubMedGoogle Scholar
• VozorisNTWangXFischerHDIncident opioid drug use among older adults with chronic obstructive pulmonary disease: a population-based cohort studyBr J Clin Pharmacol201581116117026337922
   PubMed Web of Science ®Google Scholar
• EkströmMPBornefalk-HermanssonAAbernethyAPCurrowDCSafety of benzodiazepines and opioids in very severe respiratory disease: national prospective studyBMJ2014348g44524482539
   PubMed Web of Science ®Google Scholar
• Swedish National Register for Respiratory Failure (Swedevox)Annual Report2014 Available from: www.ucr.uu.se/swedevox/Accessed October 9, 2015
   Google Scholar
• OkenMMCreechRHTormeyDCToxicity and response criteria of the Eastern Cooperative Oncology GroupAm J Clin Oncol1982566496557165009
   PubMed Web of Science ®Google Scholar
• EkströmMPHermanssonABStromKEEffects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2013187771572023328521
   PubMed Web of Science ®Google Scholar
• WettermarkBHammarNForedCMThe new Swedish Prescribed Drug Register – opportunities for pharmacoepidemiological research and experience from the first six monthsPharmacoepidemiol Drug Saf200716772673516897791
   PubMed Web of Science ®Google Scholar
• WHO Collaborating Centre for Drug Statistics MethodologyGuidelines for ATC Classification and DDD Assignment 2011WHO2010
   Google Scholar
• CurrowDCMcDonaldCOatenSOnce-daily opioids for chronic dyspnea: a dose increment and pharmacovigilance studyJ Pain Symptom Manage201142338839921458217
   PubMed Web of Science ®Google Scholar
• JanssenDJde HossonSMbij de VaateEMoorenKJBaasAAAttitudes toward opioids for refractory dyspnea in COPD among Dutch chest physiciansChron Respir Dis2015122859225676931
   PubMed Web of Science ®Google Scholar
• EkströmMNilssonFAbernethyAACurrowDCEffects of opioids on breathlessness and exercise capacity in chronic obstructive pulmonary disease: a systematic reviewAnn Am Thorac Soc20151271079109225803110
   PubMed Web of Science ®Google Scholar
• RockerGHortonRCurrowDGoodridgeDYoungJBoothSPalliation of dyspnoea in advanced COPD: revisiting a role for opioidsThorax2009641091091519786716
   PubMed Web of Science ®Google Scholar
• CurrowDCQuinnSGreeneABullJJohnsonMJAbernethyAPThe longitudinal pattern of response when morphine is used to treat chronic refractory dyspneaJ Palliat Med201316888188623746231
   PubMed Web of Science ®Google Scholar
• RockerGMSimpsonACJoanne YoungBOpioid therapy for refractory dyspnea in patients with advanced chronic obstructive pulmonary disease: patients’ experiences and outcomesCMAJ Open201311E27E36
   Google Scholar
• JohnsonMJAbernethyAPCurrowDCGaps in the evidence base of opioids for refractory breathlessness. A future work plan?J Pain Symptom Manage201243361462422285285
   PubMed Web of Science ®Google Scholar
• MularskiRACampbellMLAschSMA review of quality of care evaluation for the palliation of dyspneaAm J Respir Crit Care Med2010181653453820056904
   PubMed Web of Science ®Google Scholar
• EkströmMBornefalk-HermanssonAAbernethyACurrowDLow-dose opioids should be considered for symptom relief also in advanced chronic obstructive pulmonary disease (COPD)Evid Based Med20152013925564658
   PubMedGoogle Scholar
• EkströmMPAbernethyAPCurrowDCThe management of chronic breathlessness in patients with advanced and terminal illnessBMJ2015349g761725556037
   PubMed Web of Science ®Google Scholar